The market performance of Ultragenyx Pharmaceutical Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $60.37 on 09/16/24, while the lowest value for the same duration was $37.02 on 06/18/24.
52-week price history of RARE Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Ultragenyx Pharmaceutical Inc’s current trading price is -33.71% away from its 52-week high, while its distance from the 52-week low is 8.10%. The stock’s price range during the 52-week period has remained between $37.02 and $60.37. In the Healthcare sector, the company’s shares saw a trading volume of around 0.99 million for the day, which was evidently higher than the average daily volume of 0.84 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Ultragenyx Pharmaceutical Inc (RARE) has experienced a quarterly decline of -27.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.70B and boasts a workforce of 1276 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 51.08, with a change in price of -12.99. Similarly, Ultragenyx Pharmaceutical Inc recorded 767,994 in trading volume during the last 100 days, posting a change of -24.50%.
Examining RARE’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RARE stands at 2.63. Similarly, the long-term debt-to-equity ratio is also 2.46.
RARE Stock Stochastic Average
Ultragenyx Pharmaceutical Inc’s raw stochastic average for the past 50 days is presently 1.68%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 3.14%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 19.17% and 26.75%, respectively.
RARE Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -4.87%. However, over the past six months, we’ve seen a stronger performance of -9.99%. The price of RARE leaped by -18.09% over the last 30 days. And in the last five days, it has fallen by -6.19%.
